- Conditions
- Spasticity, Multiple Sclerosis
- Interventions
- arbaclofen, baclofen, Placebo
- Drug
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 353 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 25
- States / cities
- Cullman, Alabama • Long Beach, California • Aurora, Colorado + 20 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Acquired Blepharoptosis
- Interventions
- RVL-1201, RVL-1201 Vehicle Placebo
- Drug
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 14
- States / cities
- Artesia, California • Newport Beach, California • Rancho Cordova, California + 11 more
- Conditions
- Blepharoptosis
- Interventions
- RVL-1201, Vehicle ophthalmic solution
- Drug · Other
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 9 Years and older
- Enrollment
- 164 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 36
- States / cities
- Phoenix, Arizona • Garden Grove, California • Mission Hills, California + 30 more
- Conditions
- Blepharoptosis
- Interventions
- RVL-1201, Vehicle ophthalmic solution
- Drug · Other
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 9 Years and older
- Enrollment
- 234 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 35
- States / cities
- Phoenix, Arizona • Garden Grove, California • Mission Hills, California + 30 more
- Conditions
- Blepharoptosis
- Interventions
- RVL-1201, RVL-1201 Vehicle Placebo
- Drug
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Morrow, Georgia
- Conditions
- Multiple Sclerosis, Spasticity, Muscle
- Interventions
- Arbaclofen
- Drug
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 323 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Fresno, California
- Conditions
- Multiple Sclerosis, Spasticity
- Interventions
- arbaclofen
- Drug
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 21
- States / cities
- Gilbert, Arizona • Phoenix, Arizona • Pasadena, California + 17 more
- Conditions
- Multiple Sclerosis, Sperm
- Interventions
- arbaclofen ER Tablets, Placebo for arbaclofen ER tablets
- Drug
- Lead sponsor
- RVL Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 2
- States / cities
- Miami, Florida • Tampa, Florida